HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Autoimmune connective tissue disorder — Clinical Guidelines

Overview

Autoimmune connective tissue disorders (ACTDs) encompass a range of conditions characterized by chronic inflammation affecting connective tissues, including skin, joints, muscles, blood vessels, and internal organs. These disorders often involve complex immune dysregulation and can manifest with diverse clinical presentations such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and dermatomyositis 1 11.

Diagnosis

Clinical Presentation: Evaluate multisystem involvement and characteristic symptoms (e.g., skin changes, joint pain, muscle weakness) 1 11.

Laboratory Tests: Utilize autoantibody testing (e.g., ANA, anti-dsDNA, anti-Scl-70) to aid diagnosis 7.

Imaging Techniques: Employ nailfold capillaroscopy for early detection of microvascular changes in SSc 2.

Cardiovascular MRI: Consider for detecting myocardial involvement, particularly in suspected cardiac manifestations 8.

Management

First-Line Treatments:

- Corticosteroids: For controlling inflammation (specific doses vary by condition) 7. - Immunosuppressants: Use methotrexate, mycophenolate mofetil, or azathioprine to modulate immune response 7.

Adjunctive Therapies:

- Biologic Agents: TNF inhibitors, rituximab, or other targeted therapies based on specific disease activity and autoantibody profile 7. - Physical Therapy: To manage functional impairment and maintain joint mobility 4.

Special Populations

Pediatrics: Careful monitoring for complications and infections, especially in childhood-onset SLE and neonatal lupus syndrome 11.

Elderly: Consider comorbidities and potential drug interactions when prescribing immunosuppressive therapies 7.

Pregnancy: Close surveillance for disease flares and fetal risks; adjust immunosuppressive treatments cautiously 7.

Key Recommendations

Regular monitoring with laboratory tests and autoantibody screening is essential for early detection and management of systemic involvement in skin-predominant lupus erythematosus 7 (Evidence: Strong).

Utilize nailfold capillaroscopy as a non-invasive tool for assessing microvascular changes in patients with suspected systemic sclerosis 2 (Evidence: Moderate).

Consider cardiovascular MRI to evaluate potential cardiac involvement in patients with autoimmune connective tissue diseases, given the overlap in clinical presentations 8 (Evidence: Moderate).

Dermatologists should take primary responsibility for the care of patients with skin-predominant lupus erythematosus, dermatomyositis, and morphea, ensuring regular follow-ups and laboratory monitoring 7 (Evidence: Expert opinion).

References

1 Kouranloo K, Dey M, Elwell H, Nune A. A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19. Rheumatology international 2023. link 2 Ingegnoli F, Cornalba M, De Angelis R, Guiducci S, Giuggioli D, Pizzorni C et al.. Nailfold capillaroscopy in the rheumatological current clinical practice in Italy: results of a national survey. Reumatismo 2022. link 3 López D, Beltramo P, Acosta A. Papulolinear collagenoma: a rare entity in children. Dermatology online journal 2021. link 4 Creadore A, Watchmaker J, Maymone MBC, Pappas L, Lam C, Vashi NA. Cosmetic treatment in patients with autoimmune connective tissue diseases: Best practices for patients with morphea/systemic sclerosis. Journal of the American Academy of Dermatology 2020. link 5 Haemel A, Kahl L, Callen J, Werth VP, Fiorentino D, Fett N. Supplementing Dermatology Physician Resident Education in Vasculitis and Autoimmune Connective Tissue Disease: A Prospective Study of an Online Curriculum. JAMA dermatology 2019. link 6 Huang SW, Lin CL, Lin LF, Huang CC, Liou TH, Lin HW. Autoimmune Connective Tissue Diseases and the Risk of Rotator Cuff Repair Surgery: A Population-Based Retrospective Cohort Study. BMJ open 2019. link 7 Fett NM, Fiorentino D, Werth VP. Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea. Dermatologic clinics 2016. link 8 Mavrogeni S, Sfikakis P, Dimitroulas T, Kolovou G, Kitas GD. Edema and fibrosis imaging by cardiovascular magnetic resonance: how can the experience of Cardiology be best utilized in rheumatological practice?. Seminars in arthritis and rheumatism 2014. link 9 Lin G, Xin Z, Zhang H, Banie L, Wang G, Qiu X et al.. Identification of active and quiescent adipose vascular stromal cells. Cytotherapy 2012. link 10 Kuo HJ, Keene DR, Glanville RW. The macromolecular structure of type-VI collagen. Formation and stability of filaments. European journal of biochemistry 1995. link 11 Tucker LB. Systemic lupus erythematosus, dermatomyositis, scleroderma, vasculopathies, and other connective tissue disorders in children. Current opinion in rheumatology 1991. link 12 Daish P, Hardman MJ, Lamont MA. Hydrocephalus, tall stature, joint laxity, and kyphoscoliosis: a new inherited disorder of connective tissue?. Journal of medical genetics 1989. link 13 Inoué S, Leblond CP, Grant DS, Rico P. The microfibrils of connective tissue: II. Immunohistochemical detection of the amyloid P component. The American journal of anatomy 1986. link

Autoimmune connective tissue disorder